Monitoring Tumor Glucose Utilization by Positron Emission Tomography for the Prediction of Treatment Response to Epidermal Growth Factor Receptor Kinase InhibitorsHelen C. Su, Wolfgang Weber, Steven M. Dubinett et al.|Clinical Cancer Research|2006Cited by 204
Evaluation of [18F]gefitinib as a molecular imaging probe for the assessment of the epidermal growth factor receptor status in malignant tumorsHelen C. Su, Wolfgang Weber, Yann Seimbille et al.|European Journal of Nuclear Medicine and Molecular Imaging|2008Cited by 106